fda import alert green list glp-1 semaglutide tirzepatide 2025 Indications for GLP-1/GIP RA Summary Sheet and Beyond! FDA Drug Recalls and Warnings:

Gastrointestinal effects predominate: | Side Effect | Orforglipron | Oral Semaglutide | Tirzepatide | |-------------|-------------|-----------------|-------------| | **Nausea** | 22-28% | 24-28% | 24-31% | | **Vomiting** | 8-12% | 10-14% | 9-13% | | **Diarrhea** | 14-18% | 12-16% | 14-21% | | **Constipation** | 10-14% | 8-12% | 11-15% | | **Dyspepsia** | 6-9% | 8-11% | 5-8% | | **Discontinuation due to AEs** | ~6-8% | ~7-9% | ~4-7% | A notable difference: oral semaglutide has higher rates of upper GI symptoms (reflux, dyspepsia) because the SNAC formulation makes direct contact with gastric mucosa

One brand leading the charge is Drift, an innovative wellness company offering convenient, needle-free peptide nasal sprays that deliver targeted benefits without injections or a prescription

All animals were housed in plastic cages and fed a conventional rodent diet (21% protein, 3% crude fiber, 7% fat, 1% vitamins, and mineral premix, and 68% yellow maize, or 2490.00 Kcal/kg) on a daily basis

The appetite suppression and metabolic effects can help people stick to reduced-calorie eating patterns that were previously very challenging